A researcher with 30 retractions and counting: The whistleblower speaks

Via U.S. SEC Office of the Whistleblower

Retraction Watch readers who have been following our coverage of retractions by Ali Nazari may have noticed that an anonymous whistleblower was the person who flagged the issues for journals and publishers. That whistleblower uses the pseudonym Artemisia Stricta, and we’re pleased to present a guest post written by him or her.

Something is seriously out of place with the roughly 200 publications by Ali Nazari, a scientist at Swinburne University who studies structural materials. Some of these problems have been known by journals and publishers for years — some since 2012 — yet their response has been mixed. Some have retracted papers. Some have decided not to, so far. And others have been mum.

Continue reading A researcher with 30 retractions and counting: The whistleblower speaks

“I decline to respond” but “take this history to undermine”

via Flickr

There are various ways to respond to criticism of one’s work. There is the “well, that’s not pleasant news, but thank you, I’ll correct that straightaway” approach. There’s the “I guess we’ll correct this but hope no one notices” approach. There’s the “I’m suing you” approach — often followed by “never mind.”

And then there’s the approach taken by Barbara Fredrickson of the University of North Carolina at Chapel Hill.

Fredrickson is perhaps best known for her work on the “positivity ratio,” around which she has built a significant brand. The idea, in a nutshell, is that you’ll be more successful if you have three positive emotions for every negative one. It is a compelling and bite-sized idea, and has been turned into a book.

Continue reading “I decline to respond” but “take this history to undermine”

Materials scientist will soon be up to 30 retractions

A researcher at Swinburne University of Technology in Australia will soon add three more retractions to his burgeoning count, making 30.

Ali Nazari has lost 27 papers from several journals, as we’ve reported over the past few months. According to an upcoming notice obtained by Retraction Watch, the International Journal of Material Research (IJMR) will be retracting three more:

Continue reading Materials scientist will soon be up to 30 retractions

“Do we have the will to do anything about it?” James Heathers reflects on the Eysenck case

James Heathers

We have a tension about resolving inaccuracies in scientific documents when they’re past a certain age.

Specifically, what should we do with old papers that are shown to be not just wrong, which is a fate that will befall most of them, but seriously misleading, fatally flawed, or overwhelmingly likely to be fabricated, i.e. when they reach the (very high) threshold we set for retraction?

To my way of thinking, there are three components of this:

Continue reading “Do we have the will to do anything about it?” James Heathers reflects on the Eysenck case

University finds dozens of papers by late — and controversial — psychologist Hans Eysenck “unsafe”

Hans Eysenck

More than two dozen papers by a controversial psychologist who died in 1997 are “unsafe,” according to a recent report by his former employer obtained by Retraction Watch.

The research has been subject to question for decades, because the findings — including some that “bibliotherapy” could dramatically reduce the risk of dying from cancer — seemed unbelievable.

The report by King’s College London into the work of Hans Eysenck and Ronald Grossarth-Maticek notes that: 

Continue reading University finds dozens of papers by late — and controversial — psychologist Hans Eysenck “unsafe”

Health care group withdraws rheumatoid arthritis drug report

An influential group that studies the economic burden of medical care has temporarily removed from its website a draft report about the cost-effectiveness of drugs to treat rheumatoid arthritis amid questions about the modeling researchers used in their analysis.  

The group initially did little to explain the move, despite having issued a press release for the document last week, replacing the report’s page with a brief statement:

Continue reading Health care group withdraws rheumatoid arthritis drug report

‘Miracle’ on ice as chemists pull nanocatalyst paper that fizzled

Image by Fathromi Ramdlon from Pixabay

God giveth miracles … and it seems she taketh them away as well.

A group of chemists in China has lost a 2018 paper which described a “miraculous” discovery that wasn’t. 

The paper was titled “A miraculous chiral Ir–Rh bimetallic nanocatalyst for asymmetric hydrogenation of activated ketones,” and it appeared in Organic Chemistry Frontiers, a publication of the Royal Society of Chemistry.  

The authors, from the State Key Laboratory of Fine Chemicals at Dalian University of Technology, purported to show that: 

Continue reading ‘Miracle’ on ice as chemists pull nanocatalyst paper that fizzled

Northwestern psychology researcher out following retraction

Ping Dong

A psychology researcher at Northwestern University’s Kellogg School of Management has left a tenure-track position there less than a year after she and a co-author retracted a paper whose methods had been questioned online, Retraction Watch has learned.

Ping Dong and Chen-bo Zhong, a professor at the University of Toronto, where Dong received her PhD, retracted a paper from Psychological Science in November 2018, six months after publishing it. As we reported at the time, the paper

Continue reading Northwestern psychology researcher out following retraction

‘The problem is that there is no IL-26 gene in the mouse’ — an exasperated letter leads to a retraction

via Flickr

A group of ophthalmology researchers in China got caught trying to pull the wool over the eyes of readers by falsely claiming to have used a therapy that doesn’t exist. 

As its title would indicate, the article, “Anti-angiogenic effect of Interleukin-26 in oxygen-induced retinopathy mice via inhibiting NFATc1-VEGF pathway,” by a team from Jinhua Municipal Central Hospital in Zhejiang, purported to show that IL-26 could prevent the growth of new blood vessels in mice with damaged retinas. 

Per the abstract of the paper, which appeared in Biochemical and Biophysical Research Communications (BBRC): 

Continue reading ‘The problem is that there is no IL-26 gene in the mouse’ — an exasperated letter leads to a retraction

“A flooding accident:” Engineer has seven papers retracted at once

via U.S. Library of Congress

A chemical engineer in China who claims his supporting data were wiped out in a flood has notched his ninth retraction, seven from a single journal, for suspicious images and related issues. 

The work of Dong Ge Tong, of Chengdu University of Technology, had come under scrutiny in PubPeer, and several of his articles received expressions of concern before ultimately falling to retraction.

Last week, the Journal of Materials Chemistry A pulled seven papers on which Tong was an author. Here’s the notice for one of those articles, “Hollow amorphous NaFePO4 nanospheres as a high-capacity and high-rate cathode for sodium-ion batteries,” first published in 2015: 

Continue reading “A flooding accident:” Engineer has seven papers retracted at once